ProCE Banner Activity

CE

Confronting Inequities in Immuno-Oncology Care

Video

Watch this on-demand webcast of a live webinar for expert discussion of how pharmacists can implement patient–, provider–, and health system– level strategies to mitigate health disparities in the care of patients receiving immune checkpoint inhibitors.

Pharmacists: 1.00 contact hour (0.1 CEUs)

Released: June 16, 2022

Expiration: June 15, 2023

No longer available for credit.

Share

Faculty

Jessica Davis

Jessica Davis, PharmD, BCOP, CPP

Clinical Pharmacist Coordinator
Departmenet of Adult Hematology/Oncology
Levine Cancer Institute, Atrium Health
Charlotte, North Carolina

Kamakshi V. Rao

Kamakshi V. Rao, PharmD, BCOP, FASHP

Assistant Director
Department of Pharmacy
University of North Carolina Medical Center
Adjunct Professor of Clinical Education
Division of Practice Advancement and Clinical Education
UNC Eshelman School of Pharmacy
Chapel Hill, North Carolina

Provided by

ProCE Banner

Supporters

Supported by education grants from

Bristol Myers Squibb

Merck Sharp & Dohme Corp.

Partners

AMCP

ProCE Banner

Target Audience

The target audience for this activity is pharmacists, including managed care, specialty, and clinical pharmacists, who care for patients with cancer as well as pharmacy directors, chief pharmacy officers, and other stakeholders in pharmacy practice.

Program Learning Goal

The goal of this activity is to improve the knowledge and competence of learners in providing inclusive and equitable care for all patients with cancer, including those patients eligible for or receiving immunotherapy.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify patient populations and social determinants of health that increase risk for poor prognosis secondary to health disparities
  • Discuss management of immune-related adverse events in patient groups affected by inequalities and poor healthcare access
  • Incorporate health disparity mitigation strategies into the care of all patients receiving immune checkpoint inhibitor therapy and experiencing immune-related adverse events
  • Describe education, quality improvement, and other support strategies to ensure patients with cancer receive optimal and equitable care

Disclosure

ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Jessica Michaud Davis, PharmD, BCOP, CPP, has disclosed that she has received consulting fees from Array, Exelixis, and Regeneron/Sanofi.

Kamakshi V. Rao, PharmD, BCOP, FASHP, has no relevant conflicts of interest to report.

The planners and content peer reviewers from ProCE, LLC have no relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hours. To successfully complete this activity and receive credit, learners must follow these steps during the period from June 16, 2022, through June 15, 2023:

  1. Login or Sign Up for an account by clicking at the top of this page
  2. Read the target audience, learning objectives, and faculty disclosures
  3. View and study the content in its entirety
  4. Submit answers to the post-test questions and evaluation questions online

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by clicking the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

The program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Learners have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by healthcare professionals without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-0000-22-187-H01-P has been assigned to this home study application-based activity. This activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Completion of the evaluation and the post-test with a score of 65% or higher are required to receive CE credit. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.